re104 for
Adjustment Disorder
Reunion Neuroscience IncPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Adjustment Disorder cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Risperdal Ohio State University | Phase 3 | B |
TEONANACATL Psyence Australia Pty Ltd | Phase 2 | CCC |
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →